| 000 | 01690 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515072859.0 | ||
| 264 | 0 | _c20071102 | |
| 008 | 200711s 0 0 eng d | ||
| 022 | _a0268-3369 | ||
| 024 | 7 |
_a10.1038/sj.bmt.1705752 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFeyler, S | |
| 245 | 0 | 0 |
_aThe role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study. _h[electronic resource] |
| 260 |
_bBone marrow transplantation _cSep 2007 |
||
| 300 |
_a443-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aDisease Management |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, T-Cell _xtherapy |
| 650 | 0 | 4 |
_aLymphoma, T-Cell, Peripheral _xmortality |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTransplantation, Autologous |
| 700 | 1 | _aPrince, H M | |
| 700 | 1 | _aPearce, R | |
| 700 | 1 | _aTowlson, K | |
| 700 | 1 | _aNivison-Smith, I | |
| 700 | 1 | _aSchey, S | |
| 700 | 1 | _aGibson, J | |
| 700 | 1 | _aPatton, N | |
| 700 | 1 | _aBradstock, K | |
| 700 | 1 | _aMarks, D I | |
| 700 | 1 | _aCook, G | |
| 773 | 0 |
_tBone marrow transplantation _gvol. 40 _gno. 5 _gp. 443-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bmt.1705752 _zAvailable from publisher's website |
| 999 |
_c17126572 _d17126572 |
||